CD34 and myelodysplastic syndrome: Lastly, MVs from MDS patients have been shown to contain miR‐10, a miRNA involved in the maintenance of HSC self‐renewal (Section 2.1.9), to be able to be incorporated in CD34+ cells in vitro, and to affect their viability and clonogenic ability (Muntión et al., 2016).